Venture Life Group PLC
F:17V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Venture Life Group PLC
F:17V
|
UK |
|
G
|
Gogo Inc
F:G0G
|
US |
|
Precision BioSciences Inc
F:PBS0
|
US |
|
G
|
Gibraltar Industries Inc
F:GI2
|
US |
|
CPH Chemie und Papier Holding AG
SIX:CPHN
|
CH |
|
M
|
Mattel Inc
XHAN:MTT
|
US |
|
M
|
MPC Energy Solutions NV
OSE:MPCES
|
NL |
|
L
|
Lucky Cement Ltd
KAR:LUCK
|
PK |
|
V
|
Vinci SA
XHAN:SQU
|
FR |
|
Guillemot Corporation SA
F:GUL
|
FR |
|
N
|
National Bank of Pakistan
KAR:NBP
|
PK |
Venture Life Group PLC
Venture Life Group makes and sells non-prescription healthcare and personal care products. Its range includes oral care, feminine care, advanced wound care, skincare, digestion and other consumer health items, along with some medical devices. The company sells both under its own brands and as private-label products made for retailers and other companies. Its main customers are pharmacies, supermarkets, healthcare retailers, distributors and other consumer health businesses that need ready-made products or manufacturing support. Venture Life also develops products for third parties and produces them in its own facilities or through contract manufacturing arrangements. It earns money when customers buy its branded products, private-label goods and development or manufacturing services. What makes the business model distinctive is that it sits between product developer and manufacturer. It does not just market finished brands; it also helps create, formulate and make products that other companies can sell under their own names. That gives it a mix of recurring consumer sales and B2B service revenue, tied to everyday health and hygiene categories rather than prescription medicine.
Venture Life Group makes and sells non-prescription healthcare and personal care products. Its range includes oral care, feminine care, advanced wound care, skincare, digestion and other consumer health items, along with some medical devices. The company sells both under its own brands and as private-label products made for retailers and other companies.
Its main customers are pharmacies, supermarkets, healthcare retailers, distributors and other consumer health businesses that need ready-made products or manufacturing support. Venture Life also develops products for third parties and produces them in its own facilities or through contract manufacturing arrangements. It earns money when customers buy its branded products, private-label goods and development or manufacturing services.
What makes the business model distinctive is that it sits between product developer and manufacturer. It does not just market finished brands; it also helps create, formulate and make products that other companies can sell under their own names. That gives it a mix of recurring consumer sales and B2B service revenue, tied to everyday health and hygiene categories rather than prescription medicine.
Revenue Growth: Group revenue rose 43% to GBP 15.4 million, with 12.5% organic growth, driven by both UK consumer brands and international markets.
Health & Her Acquisition: The Health & Her business contributed GBP 4 million in the first half, boosting reported growth and improving margins due to higher product profitability.
Margin Expansion: Gross margin increased to 43.1%, up from 41.2% last year, aided by the mix shift from higher-margin brands.
Marketing Investment: Marketing spend rose to 10.5% of group sales (14.5% on supported brands), targeting brand awareness and long-term revenue acceleration.
Cash Position & Firepower: Following the CDMO divestment, net cash was GBP 34 million at September end, with up to GBP 85 million available for acquisitions.
Brand Performance: Strong growth in women's health (Balance Activ up 24%) and Health & Her (up 35%), but energy management brands declined due to a temporary NHS ordering issue.
Strategic Refocus: The company completed its shift to a capital-light, brand-led model, divesting manufacturing and non-core brands to focus on high-margin categories.
Outlook: Management is confident in continued organic growth, margin improvement, and upcoming acquisitions, with a strong emphasis on innovation, digital, and international expansion.
